Loading
If this is the first time anyone has visited this substance, we may be fetching live data from TGA Product Information, PBS, and state framework sources — that can take up to a minute. Cached substances load in a second or two.
Assisted Reproductive Technology Clinical criteria: Patient must be receiving medical services as described in items 13200, 13201, 13202 or 13203 of the Medicare Benefits Schedule.
Infertility Clinical criteria: The condition must be due to hypogonadotrophic hypogonadism, AND The treatment must be following failure of 6 months' treatment with human chorionic gonadotrophin to achieve adequate spermatogenesis, AND The treatment must be administered with human chorionic gonadotrophin.
“PUREGON contains follitropin beta, a recombinant human FSH. FSH is indispensable in normal gamete growth and maturation, and gonadal steroid production.”
“Due to the sustained release from the injection site, and the relatively long elimination half-life of about 40 hours (ranging from 12 to 70 hours), follitropin beta levels remain high for 24-48 hours.”
Working under the parallel aged-care framework? Aged-care equivalent →
Curated subset. The full adverse-effect list is in the TGA Product Information; click any citation above to open it.